vs
Side-by-side financial comparison of ARMSTRONG WORLD INDUSTRIES INC (AWI) and Axsome Therapeutics, Inc. (AXSM). Click either name above to swap in a different company.
ARMSTRONG WORLD INDUSTRIES INC is the larger business by last-quarter revenue ($388.3M vs $196.0M, roughly 2.0× Axsome Therapeutics, Inc.). ARMSTRONG WORLD INDUSTRIES INC runs the higher net margin — 16.9% vs -14.6%, a 31.4% gap on every dollar of revenue. On growth, Axsome Therapeutics, Inc. posted the faster year-over-year revenue change (65.0% vs 5.6%). ARMSTRONG WORLD INDUSTRIES INC produced more free cash flow last quarter ($62.2M vs $-18.7M). Over the past eight quarters, Axsome Therapeutics, Inc.'s revenue compounded faster (61.7% CAGR vs 9.1%).
Armstrong World Industries, Inc. is an international designer and manufacturer of wall and ceiling building materials based in Lancaster, Pennsylvania. As of 2014, AWI had 3,100 employees and a global manufacturing network of 17 facilities, down from 26, including nine plants dedicated to its WAVE joint venture, in 2012.
Jazz Pharmaceuticals plc is a global biopharmaceutical company with a focus on oncology and neuroscience. It was founded in 2003 in California, United States and is now headquartered in Dublin, Ireland.
AWI vs AXSM — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | ||
|---|---|---|
| Revenue | $388.3M | $196.0M |
| Net Profit | $65.5M | $-28.6M |
| Gross Margin | 39.8% | — |
| Operating Margin | 23.7% | -13.8% |
| Net Margin | 16.9% | -14.6% |
| Revenue YoY | 5.6% | 65.0% |
| Net Profit YoY | 5.3% | 61.9% |
| EPS (diluted) | $1.51 | $-0.55 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $388.3M | $196.0M | ||
| Q3 25 | $425.2M | $171.0M | ||
| Q2 25 | $424.6M | $150.0M | ||
| Q1 25 | $382.7M | $121.5M | ||
| Q4 24 | $367.7M | $118.8M | ||
| Q3 24 | $386.6M | $104.8M | ||
| Q2 24 | $365.1M | $87.2M | ||
| Q1 24 | $326.3M | $75.0M |
| Q4 25 | $65.5M | $-28.6M | ||
| Q3 25 | $86.3M | $-47.2M | ||
| Q2 25 | $87.8M | $-48.0M | ||
| Q1 25 | $69.1M | $-59.4M | ||
| Q4 24 | $62.2M | $-74.9M | ||
| Q3 24 | $76.9M | $-64.6M | ||
| Q2 24 | $65.9M | $-79.3M | ||
| Q1 24 | $59.9M | $-68.4M |
| Q4 25 | 39.8% | — | ||
| Q3 25 | 42.0% | — | ||
| Q2 25 | 41.4% | — | ||
| Q1 25 | 39.2% | — | ||
| Q4 24 | 39.1% | — | ||
| Q3 24 | 42.4% | — | ||
| Q2 24 | 40.9% | — | ||
| Q1 24 | 38.1% | — |
| Q4 25 | 23.7% | -13.8% | ||
| Q3 25 | 27.6% | -27.0% | ||
| Q2 25 | 29.0% | -24.5% | ||
| Q1 25 | 25.7% | -46.9% | ||
| Q4 24 | 22.3% | -61.1% | ||
| Q3 24 | 28.8% | -59.8% | ||
| Q2 24 | 26.0% | -89.5% | ||
| Q1 24 | 26.4% | -89.7% |
| Q4 25 | 16.9% | -14.6% | ||
| Q3 25 | 20.3% | -27.6% | ||
| Q2 25 | 20.7% | -32.0% | ||
| Q1 25 | 18.1% | -48.9% | ||
| Q4 24 | 16.9% | -63.1% | ||
| Q3 24 | 19.9% | -61.7% | ||
| Q2 24 | 18.0% | -91.0% | ||
| Q1 24 | 18.4% | -91.1% |
| Q4 25 | $1.51 | $-0.55 | ||
| Q3 25 | $1.98 | $-0.94 | ||
| Q2 25 | $2.01 | $-0.97 | ||
| Q1 25 | $1.58 | $-1.22 | ||
| Q4 24 | $1.41 | $-1.54 | ||
| Q3 24 | $1.75 | $-1.34 | ||
| Q2 24 | $1.50 | $-1.67 | ||
| Q1 24 | $1.36 | $-1.44 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $112.7M | $322.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $900.7M | $88.3M |
| Total Assets | $1.9B | $689.8M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $112.7M | $322.9M | ||
| Q3 25 | $90.1M | $325.3M | ||
| Q2 25 | $81.1M | $303.0M | ||
| Q1 25 | $82.8M | $300.9M | ||
| Q4 24 | $79.3M | $315.4M | ||
| Q3 24 | $73.7M | $327.3M | ||
| Q2 24 | $73.6M | $315.7M | ||
| Q1 24 | $69.6M | $331.4M |
| Q4 25 | $900.7M | $88.3M | ||
| Q3 25 | $889.2M | $73.7M | ||
| Q2 25 | $837.8M | $73.1M | ||
| Q1 25 | $793.4M | $53.2M | ||
| Q4 24 | $757.1M | $57.0M | ||
| Q3 24 | $717.0M | $92.9M | ||
| Q2 24 | $669.0M | $102.9M | ||
| Q1 24 | $626.8M | $144.0M |
| Q4 25 | $1.9B | $689.8M | ||
| Q3 25 | $1.9B | $669.3M | ||
| Q2 25 | $1.9B | $639.8M | ||
| Q1 25 | $1.9B | $596.7M | ||
| Q4 24 | $1.8B | $568.5M | ||
| Q3 24 | $1.8B | $561.5M | ||
| Q2 24 | $1.8B | $548.2M | ||
| Q1 24 | $1.7B | $545.7M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $110.0M | $-18.7M |
| Free Cash FlowOCF − Capex | $62.2M | $-18.7M |
| FCF MarginFCF / Revenue | 16.0% | -9.6% |
| Capex IntensityCapex / Revenue | 12.3% | 0.0% |
| Cash ConversionOCF / Net Profit | 1.68× | — |
| TTM Free Cash FlowTrailing 4 quarters | $246.1M | $-93.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $110.0M | $-18.7M | ||
| Q3 25 | $122.9M | $1.0M | ||
| Q2 25 | $81.6M | $-32.4M | ||
| Q1 25 | $41.0M | $-43.4M | ||
| Q4 24 | $86.6M | $-26.2M | ||
| Q3 24 | $96.5M | $-18.6M | ||
| Q2 24 | $57.3M | $-30.1M | ||
| Q1 24 | $26.4M | $-53.5M |
| Q4 25 | $62.2M | $-18.7M | ||
| Q3 25 | $100.3M | $988.0K | ||
| Q2 25 | $61.7M | $-32.4M | ||
| Q1 25 | $21.9M | $-43.7M | ||
| Q4 24 | $57.8M | $-26.2M | ||
| Q3 24 | $77.1M | $-18.7M | ||
| Q2 24 | $37.4M | $-30.2M | ||
| Q1 24 | $11.7M | $-53.6M |
| Q4 25 | 16.0% | -9.6% | ||
| Q3 25 | 23.6% | 0.6% | ||
| Q2 25 | 14.5% | -21.6% | ||
| Q1 25 | 5.7% | -36.0% | ||
| Q4 24 | 15.7% | -22.1% | ||
| Q3 24 | 19.9% | -17.9% | ||
| Q2 24 | 10.2% | -34.6% | ||
| Q1 24 | 3.6% | -71.4% |
| Q4 25 | 12.3% | 0.0% | ||
| Q3 25 | 5.3% | 0.0% | ||
| Q2 25 | 4.7% | 0.0% | ||
| Q1 25 | 5.0% | 0.3% | ||
| Q4 24 | 7.8% | 0.0% | ||
| Q3 24 | 5.0% | 0.1% | ||
| Q2 24 | 5.5% | 0.1% | ||
| Q1 24 | 4.5% | 0.1% |
| Q4 25 | 1.68× | — | ||
| Q3 25 | 1.42× | — | ||
| Q2 25 | 0.93× | — | ||
| Q1 25 | 0.59× | — | ||
| Q4 24 | 1.39× | — | ||
| Q3 24 | 1.25× | — | ||
| Q2 24 | 0.87× | — | ||
| Q1 24 | 0.44× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AWI
| Distributors | $183.0M | 47% |
| Architectural Specialties | $143.7M | 37% |
| Home Centers | $27.2M | 7% |
| Retailers And Other | $21.7M | 6% |
| Direct Customers | $12.7M | 3% |
AXSM
Segment breakdown not available.